Deep Eutectic Solvents for Subcutaneous Delivery of Protein Therapeutics
Advanced Science · 2023-03 · 10 (7)
DOI: 10.1002/advs.202205389 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 15.01.2023. Verfasst von Alexander M Curreri und 6 weiteren Autor:innen. Beteiligte Einrichtung: John A. Paulson School of Engineering and Applied Sciences, Harvard University, 150 Western Ave, Allston, MA, 02134, USA. Hauptthemen laut MEDLINE: Deep Eutectic Solvents, Biological Products. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Proteins are among the most common therapeutics for the treatment of diabetes, autoimmune diseases, cancer, and metabolic diseases, among others. Despite their common use, current protein therapies, most of which are injectables, have several limitations. Large proteins such as monoclonal antibodies (mAbs) suffer from poor absorption after subcutaneous injections, thus forcing their administration by intravenous injections. Even small proteins such as insulin suffer from slow pharmacokinetics which poses limitations in effective management of diabetes. Here, a deep eutectic‐based delivery strategy is used to offer a generalized approach for improving protein absorption after subcutaneous injections. The lead formulation enhances absorption of mAbs after subcutaneous injections by ≈200%. The same composition also improves systemic absorption of subcutaneously injected insulin faster than Humalog, the current gold‐standard of rapid acting insulin. Mechanistic studies reveal that the beneficial effect of deep eutectics on subcutaneous absorption is mediated by their ability to reduce the interactions of proteins with the subcutaneous matrix, especially collagen. Studies also confirm that these deep eutectics are safe for subcutaneous injections. Deep eutectic‐based formulations described here open new possibilities for subcutaneous injections of therapeutic proteins.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- John A. Paulson School of Engineering and Applied Sciences, Harvard University, 150 Western Ave, Allston, MA, 02134, USA.
- Wyss Institute for Biologically Inspired Engineering at Harvard University, 3 Blackfan St, Boston, MA, 02115, USA.
ORCID-Profile: Samir Mitragotri
Zitieren
APA
Curreri, A. M., Kim, J., Dunne, M., Angsantikul, P., Goetz, M., Gao, Y., & Mitragotri, S. (2023). Deep Eutectic Solvents for Subcutaneous Delivery of Protein Therapeutics. Advanced Science, 10(7). https://doi.org/10.1002/advs.202205389
Vancouver
Curreri AM, Kim J, Dunne M, Angsantikul P, Goetz M, Gao Y, et al. Deep Eutectic Solvents for Subcutaneous Delivery of Protein Therapeutics. Advanced Science. 2023;10(7). doi:10.1002/advs.202205389
BibTeX
@article{Curreri2023,
author = {Curreri, Alexander M and Kim, Jayoung and Dunne, Michael and Angsantikul, Pavimol and Goetz, Morgan and Gao, Yongsheng and Mitragotri, Samir},
title = {Deep Eutectic Solvents for Subcutaneous Delivery of Protein Therapeutics},
journal = {Advanced Science},
year = {2023},
volume = {10},
number = {7},
doi = {10.1002/advs.202205389}
}
EUVIMED